BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12229255)

  • 1. [Beta blockers in post-infarction state].
    Schultheiss HP; Tschöpe C
    Herz; 2002 Aug; 27 Suppl 1():26-9. PubMed ID: 12229255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
    Colucci WS
    Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI.
    Coats AJ
    Int J Cardiol; 2001 Apr; 78(2):109-13. PubMed ID: 11334653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and methodology of the CAPRICORN trial - a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction.
    Dargie HJ
    Eur J Heart Fail; 2000 Sep; 2(3):325-32. PubMed ID: 10938495
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
    Dargie HJ
    Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol: a review of its use in chronic heart failure.
    Keating GM; Jarvis B
    Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 14. [Congestive heart failure and acute myocardial infarction: latest trials with beta-blocking agents].
    Isnard R
    Ann Cardiol Angeiol (Paris); 2002 Jan; 51(1):48-50. PubMed ID: 12510669
    [No Abstract]   [Full Text] [Related]  

  • 15. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal hyperactivity in heart failure. Differences in beta blockers].
    Beuckelmann DJ
    Herz; 2002 Aug; 27 Suppl 1():9-15. PubMed ID: 12229258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major beta blocker mortality trials in chronic heart failure: a critical review.
    McMurray JJ
    Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe heart failure--effects of carvedilol therapy. The Copernicus Study].
    Kindermann M; Böhm M
    Internist (Berl); 2002 Feb; 43(2):284-6. PubMed ID: 11963765
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of carvedilol on mortality and morbidity in patients with chronic heart failure.
    Circulation; 1996 Aug; 94(4):592. PubMed ID: 8772669
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.